Acceleron Pharma and Celgene Collaborate Again in Anaemia
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 8 (Table of Contents)
Published: 15 Aug-2011
DOI: 10.3833/pdr.v2011.i8.1522 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Acceleron Pharma and Celgene have signed their second collaboration in anaemia, this time an agreement potentially worth US$242 M to develop and commercialise Acceleron’s ACE-536, a novel protein therapeutic for the treatment of myelodysplastic syndromes...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS